132 related articles for article (PubMed ID: 33647739)
1. Dual-target platinum(IV) complexes exhibit antiproliferative activity through DNA damage and induce ER-stress-mediated apoptosis in A549 cells.
Wang M; Liu Z; Huang X; Chen Y; Wang Y; Kong J; Yang Y; Yu C; Li J; Wang X; Wang H
Bioorg Chem; 2021 May; 110():104741. PubMed ID: 33647739
[TBL] [Abstract][Full Text] [Related]
2. Mitochondria-targeted platinum(II) complexes induce apoptosis-dependent autophagic cell death mediated by ER-stress in A549 cancer cells.
Wang FY; Tang XM; Wang X; Huang KB; Feng HW; Chen ZF; Liu YN; Liang H
Eur J Med Chem; 2018 Jul; 155():639-650. PubMed ID: 29935437
[TBL] [Abstract][Full Text] [Related]
3. Dual-targeting antitumor conjugates derived from platinum(IV) prodrugs and microtubule inhibitor CA-4 significantly exhibited potent ability to overcome cisplatin resistance.
Huang X; Wang M; Wang C; Hu W; You Q; Yang Y; Yu C; Liao Z; Gou S; Wang H
Bioorg Chem; 2019 Nov; 92():103236. PubMed ID: 31494328
[TBL] [Abstract][Full Text] [Related]
4. Targeting RAS-RAF pathway significantly improves antitumor activity of Rigosertib-derived platinum(IV) complexes and overcomes cisplatin resistance.
Liu Z; Wang M; Wang H; Fang L; Gou S
Eur J Med Chem; 2020 May; 194():112269. PubMed ID: 32248002
[TBL] [Abstract][Full Text] [Related]
5. Chlorambucil-conjugated platinum(IV) prodrugs to treat triple-negative breast cancer in vitro and in vivo.
Ma ZY; Wang DB; Song XQ; Wu YG; Chen Q; Zhao CL; Li JY; Cheng SH; Xu JY
Eur J Med Chem; 2018 Sep; 157():1292-1299. PubMed ID: 30195239
[TBL] [Abstract][Full Text] [Related]
6. Novel NF-κB Inhibitor-Conjugated Pt(IV) Prodrug to Enable Cancer Therapy through ROS/ER Stress and Mitochondrial Dysfunction and Overcome Multidrug Resistance.
Wang M; Li G; Jiang G; Cai J; Liu Z; Huang R; Huang X; Wang H
J Med Chem; 2024 Apr; 67(8):6218-6237. PubMed ID: 38573870
[TBL] [Abstract][Full Text] [Related]
7. Complexes of oxoplatin with rhein and ferulic acid ligands as platinum(iv) prodrugs with high anti-tumor activity.
Tan MX; Wang ZF; Qin QP; Zou BQ; Liang H
Dalton Trans; 2020 Feb; 49(5):1613-1619. PubMed ID: 31942585
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of dihydro-2-quinolone platinum(iv) hybrids as antitumor agents displaying mitochondria injury and DNA damage mechanism.
Liu Z; Li Z; Du T; Chen Y; Wang Q; Li G; Liu M; Zhang N; Li D; Han J
Dalton Trans; 2021 Jan; 50(1):362-375. PubMed ID: 33319888
[TBL] [Abstract][Full Text] [Related]
9. E platinum, a newly synthesized platinum compound, induces apoptosis through ROS-triggered ER stress in gastric carcinoma cells.
Wang X; Guo Q; Tao L; Zhao L; Chen Y; An T; Chen Z; Fu R
Mol Carcinog; 2017 Jan; 56(1):218-231. PubMed ID: 27061377
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of a novel series of glycosylated platinum(iv) complexes as antitumor agents.
Wang Q; Huang Z; Ma J; Lu X; Zhang L; Wang X; George Wang P
Dalton Trans; 2016 Jun; 45(25):10366-74. PubMed ID: 27252024
[TBL] [Abstract][Full Text] [Related]
11. Conjugation of platinum(IV) complexes with chlorambucil to overcome cisplatin resistance via a "joint action" mode toward DNA.
Qin X; Fang L; Chen F; Gou S
Eur J Med Chem; 2017 Sep; 137():167-175. PubMed ID: 28586717
[TBL] [Abstract][Full Text] [Related]
12. The Effects of Newly Synthesized Platinum(IV) Complexes on Cytotoxicity and Radiosensitization of Human Tumour Cells
Petrovic M; Popovic S; Baskic D; Todorovic M; Djurdjevic P; Ristic-Fira A; Keta O; Petkovic V; Koricanac L; Stojkovic D; Jevtic V; Trifunovic S; Todorovic D
Anticancer Res; 2020 Sep; 40(9):5001-5013. PubMed ID: 32878788
[TBL] [Abstract][Full Text] [Related]
13. 5-Bromo-oxoisoaporphine platinum(II) complexes exhibit tumor cell cytotoxcicity via inhibition of telomerase activity and disruption of c-myc G-quadruplex DNA and mitochondrial functions.
Wei ZZ; Qin QP; Meng T; Deng CX; Liang H; Chen ZF
Eur J Med Chem; 2018 Feb; 145():360-369. PubMed ID: 29335202
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of naphthalenebenzimidizole platinum (II) complexes as potential antitumor agents.
Liang GB; Yu YC; Wei JH; Kuang WB; Chen ZF; Zhang Y
Eur J Med Chem; 2020 Feb; 188():112033. PubMed ID: 31923857
[TBL] [Abstract][Full Text] [Related]
15. Maximizing Synergistic Activity When Combining RNAi and Platinum-Based Anticancer Agents.
Xiao H; Qi R; Li T; Awuah SG; Zheng Y; Wei W; Kang X; Song H; Wang Y; Yu Y; Bird MA; Jing X; Yaffe MB; Birrer MJ; Ghoroghchian PP
J Am Chem Soc; 2017 Mar; 139(8):3033-3044. PubMed ID: 28166401
[TBL] [Abstract][Full Text] [Related]
16. On the stability and biological behavior of cyclometallated Pt(IV) complexes with halido and aryl ligands in the axial positions.
Escolà A; Crespo M; López C; Quirante J; Jayaraman A; Polat IH; Badía J; Baldomà L; Cascante M
Bioorg Med Chem; 2016 Nov; 24(22):5804-5815. PubMed ID: 27670096
[TBL] [Abstract][Full Text] [Related]
17. Naproxen platinum(iv) hybrids inhibiting cycloxygenases and matrix metalloproteinases and causing DNA damage: synthesis and biological evaluation as antitumor agents in vitro and in vivo.
Chen Y; Wang Q; Li Z; Liu Z; Zhao Y; Zhang J; Liu M; Wang Z; Li D; Han J
Dalton Trans; 2020 Apr; 49(16):5192-5204. PubMed ID: 32236281
[TBL] [Abstract][Full Text] [Related]
18. Enhancing Cytotoxicity of a Monofunctional Platinum Complex via a Dual-DNA-Damage Approach.
Guo Y; He Y; Wu S; Zhang S; Song D; Zhu Z; Guo Z; Wang X
Inorg Chem; 2019 Oct; 58(19):13150-13160. PubMed ID: 31539237
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of a new series of low toxic naphthalimide platinum(IV) antitumor complexes with dual DNA damage mechanism.
Wang Q; Tan X; Liu Z; Li G; Zhang R; Wei J; Wang S; Li D; Wang B; Han J
Eur J Pharm Sci; 2018 Nov; 124():127-136. PubMed ID: 30153524
[TBL] [Abstract][Full Text] [Related]
20. A novel star-shaped trinuclear platinum(II) complex based on a 1,3,5-triazine core displaying potent antiproliferative activity against TNBC by the mitochondrial injury and DNA damage mechanism.
Wu Y; Zhao D; Shang J; Huang W; Chen Z
Dalton Trans; 2022 Jul; 51(29):10930-10942. PubMed ID: 35731536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]